December 2016 – The U.S. Food and Drug Administration (FDA) finalized its guidance intended for institutional review boards (IRBs), investigators, and sponsors engaged in (or responsible for) oversight of human subject research under the Department of Health and Human...
Ed Silverman from the Wall Street Journal wrote an interesting article on the need for more social media presence from pharmaceutical companies in clinical trial arena. Silverman feels that pharma companies may be dropping the ball on using social media to promote and...
Single IRB – A Guide to the Common Rule sIRB Mandate
The sIRB requirement is active. Is your study affected?
